Testing reminder messages for lung cancer screening
Reminder Messages for Lung Cancer Screening
This study is trying out reminder messages for lung cancer screening to see if they help adults aged 50 to 80 who smoke or used to smoke get screened more often.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 130 (estimated) |
| Ages | 40 Years to 80 Years |
| Sex | All |
| Sponsor | M.D. Anderson Cancer Center Academic / other |
| Locations | 1 site (Houston, Texas) |
| Trial ID | NCT05952778 on ClinicalTrials.gov |
What this trial studies
This project aims to develop and test reminder messages for lung cancer screening (LCS) targeted at adults aged 50 to 80 who smoke or have a history of smoking. The study will focus on ensuring that these reminders are acceptable to patients with a history of cigarette use. Participants will be involved in various activities such as focus groups, cognitive interviews, and surveys to refine the messaging approach. The goal is to improve screening rates among at-risk populations.
Who should consider this trial
Good fit: Ideal candidates are adults aged 50 to 80 who currently smoke or have smoked in the past and do not have a history of lung cancer.
Not a fit: Patients with a history of lung cancer will not benefit from this study.
Why it matters
Potential benefit: If successful, this could lead to increased lung cancer screening rates and earlier detection for at-risk patients.
How similar studies have performed: Other studies have shown success in using reminder messages to improve screening rates, indicating that this approach has potential.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults ages 40-80 years * Currently use combustible tobacco products or used combustible tobacco products in the past * English or Spanish speaker (based on self-report) Or an adult caregiver/care partner or family member of someone with a history of combustible tobacco product use (may participate in focus groups, cognitive interviews, surveys) Exclusion Criteria: • History of lung cancer (based on self-report)
Where this trial is running
Houston, Texas
- M D Anderson Cancer Center — Houston, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Robert Volk, MD — M.D. Anderson Cancer Center
- Study coordinator: Robert Volk, MD
- Email: bvolk@mdanderson.org
- Phone: (713) 563-2509
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.